DCF — ADVENTHEALTH GORDON
Enterprise Value: $-125.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-125.4M
Enterprise Value
$-43.5M
PV of Cash Flows
$-81.8M
PV of Terminal Value
$-131.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $194.1M | $-5.7M | -3.0% | $-13.9M | $-12.6M |
| Year 2 | $199.9M | $-3.9M | -2.0% | $-12.3M | $-10.2M |
| Year 3 | $205.9M | $-1.9M | -1.0% | $-10.6M | $-8.0M |
| Year 4 | $212.1M | $-0.9M | -0.0% | $-9.9M | $-6.8M |
| Year 5 | $218.5M | $-0.4M | -0.0% | $-9.6M | $-6.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-125.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$188.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03429183968750257
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5